Literature DB >> 26224633

Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Sara Calattini, Floriane Fusil, Jimmy Mancip, Viet Loan Dao Thi, Christelle Granier, Nicolas Gadot1, Jean-Yves Scoazec1, Mirjam B Zeisel2, Thomas F Baumert, Dimitri Lavillette, Marlène Dreux3, François-Loïc Cosset4.   

Abstract

Lipoprotein components are crucial factors for hepatitis C virus (HCV) assembly and entry. As hepatoma cells producing cell culture-derived HCV (HCVcc) particles are impaired in some aspects of lipoprotein metabolism, it is of upmost interest to biochemically and functionally characterize the in vivo produced viral particles, particularly regarding how lipoprotein components modulate HCV entry by lipid transfer receptors such as scavenger receptor BI (SR-BI). Sera from HCVcc-infected liver humanized FRG mice were separated by density gradients. Viral subpopulations, termed HCVfrg particles, were characterized for their physical properties, apolipoprotein association, and infectivity. We demonstrate that, in contrast to the widely spread distribution of apolipoproteins across the different HCVcc subpopulations, the most infectious HCVfrg particles are highly enriched in apoE, suggesting that such apolipoprotein enrichment plays a role for entry of in vivo derived infectious particles likely via usage of apolipoprotein receptors. Consistent with this salient feature, we further reveal previously undefined functionalities of SR-BI in promoting entry of in vivo produced HCV. First, unlike HCVcc, SR-BI is a particularly limiting factor for entry of HCVfrg subpopulations of very low density. Second, HCVfrg entry involves SR-BI lipid transfer activity but not its capacity to bind to the viral glycoprotein E2. In conclusion, we demonstrate that composition and biophysical properties of the different subpopulations of in vivo produced HCVfrg particles modulate their levels of infectivity and receptor usage, hereby featuring divergences with in vitro produced HCVcc particles and highlighting the powerfulness of this in vivo model for the functional study of the interplay between HCV and liver components.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  animal model; apolipoprotein; hepatitis C virus (HCV); in vivo study; lipoprotein; scavenger receptor; virus entry

Mesh:

Substances:

Year:  2015        PMID: 26224633      PMCID: PMC4645586          DOI: 10.1074/jbc.M115.662999

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Dietary myristic acid modifies the HDL-cholesterol concentration and liver scavenger receptor BI expression in the hamster.

Authors:  Carole Loison; François Mendy; Colette Sérougne; Claude Lutton
Journal:  Br J Nutr       Date:  2002-03       Impact factor: 3.718

2.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

3.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.

Authors:  Yan Xu; Pierre Martinez; Karin Séron; Guangxiang Luo; Fabrice Allain; Jean Dubuisson; Sandrine Belouzard
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

Review 5.  The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders.

Authors:  David Rhainds; Louise Brissette
Journal:  Int J Biochem Cell Biol       Date:  2004-01       Impact factor: 5.085

6.  Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.

Authors:  Heidi Barth; Christiane Schafer; Mohammed I Adah; Fuming Zhang; Robert J Linhardt; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Toshihiko Toida; Toin H Van Kuppevelt; Erik Depla; Fritz Von Weizsacker; Hubert E Blum; Thomas F Baumert
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

7.  Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.

Authors:  P André; F Komurian-Pradel; S Deforges; M Perret; J L Berland; M Sodoyer; S Pol; C Bréchot; G Paranhos-Baccalà; V Lotteau
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice.

Authors:  Pablo Mardones; Antoine Pilon; Muriel Bouly; Daniel Duran; Takako Nishimoto; Hiroyuki Arai; Karen F Kozarsky; Marcela Altayo; Juan Francisco Miquel; Gerald Luc; Veronique Clavey; Bart Staels; Attilio Rigotti
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

9.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

10.  Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.

Authors:  Takasuke Fukuhara; Masami Wada; Shota Nakamura; Chikako Ono; Mai Shiokawa; Satomi Yamamoto; Takashi Motomura; Toru Okamoto; Daisuke Okuzaki; Masahiro Yamamoto; Izumu Saito; Takaji Wakita; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

View more
  16 in total

1.  Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.

Authors:  Murali Ganesan; Sathish Kumar Natarajan; Jinjin Zhang; Justin L Mott; Larisa I Poluektova; Benita L McVicker; Kusum K Kharbanda; Dean J Tuma; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-07       Impact factor: 4.052

2.  Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.

Authors:  Zaili Yang; Xiaoning Wang; Xiumei Chi; Fanfan Zhao; Jinxu Guo; Pengjuan Ma; Jin Zhong; Junqi Niu; Xiaoyu Pan; Gang Long
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 3.  Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.

Authors:  Viviana Falcón; Nelson Acosta-Rivero; Sirenia González; Santiago Dueñas-Carrera; Gillian Martinez-Donato; Ivon Menéndez; Rocio Garateix; José A Silva; Emilio Acosta; Juan Kourı
Journal:  Virus Genes       Date:  2017-02-23       Impact factor: 2.332

4.  TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.

Authors:  Audrey Boyer; Seung Bum Park; Ynto S de Boer; Qisheng Li; T Jake Liang
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

5.  The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.

Authors:  Solène Denolly; Chloé Mialon; Thomas Bourlet; Fouzia Amirache; François Penin; Brett Lindenbach; Bertrand Boson; François-Loïc Cosset
Journal:  PLoS Pathog       Date:  2017-12-18       Impact factor: 6.823

6.  Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.

Authors:  Ursula Andreo; Ype P de Jong; Margaret A Scull; Jing W Xiao; Koen Vercauteren; Corrine Quirk; Michiel C Mommersteeg; Sonia Bergaya; Arjun Menon; Edward A Fisher; Charles M Rice
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-07-19

Review 7.  Engineered Livers for Infectious Diseases.

Authors:  Nil Gural; Liliana Mancio-Silva; Jiang He; Sangeeta N Bhatia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-11-22

8.  Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.

Authors:  Julie Lucifora; Marc Bonnin; Ludovic Aillot; Floriane Fusil; Sarah Maadadi; Laura Dimier; Maud Michelet; Océane Floriot; Anaïs Ollivier; Michel Rivoire; Malika Ait-Goughoulte; Stéphane Daffis; Simon P Fletcher; Anna Salvetti; François-Loïc Cosset; Fabien Zoulim; David Durantel
Journal:  Sci Rep       Date:  2018-03-29       Impact factor: 4.379

Review 9.  Hepatitis C virus: Morphogenesis, infection and therapy.

Authors:  Vladimir Alexei Morozov; Sylvie Lagaye
Journal:  World J Hepatol       Date:  2018-02-27

Review 10.  Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance.

Authors:  Ahmed Atef Mesalam; Koen Vercauteren; Philip Meuleman
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.